Fundamentals-based quality & risk · not a recommendation
CINEVISTA scores 30/100 (Avoid) on the Orion Score — poor business quality (7), strong growth (80) and weak balance-sheet safety (33). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
73/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹7.3 | ₹0.82 | 41.8% | ₹0.00 |
| Q3 2026 | ₹8.25 | ₹3.52 | 50.2% | ₹0.00 |
| Q2 2026 | ₹3.79 | ₹0.77 | 39.8% | ₹0.00 |
| Q1 2026 | ₹4.63 | ₹0.99 | 41.0% | ₹0.17 |
| Q4 2025 | ₹11.47 | ₹-25.87 | -132.3% | ₹0.00 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2025 | ₹11.54 | ₹-31.62 | ₹-17.91 | -126.1% |
| FY 2024 | ₹0.44 | ₹-7.5 | ₹-3.52 | -904.5% |
| FY 2023 | ₹0.8 | ₹-27.98 | ₹-38.93 | -4836.3% |
| FY 2022 | ₹1.02 | ₹-16.49 | ₹-9.56 | -329.4% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹145.59 | ₹178.29 | ₹175.05 | ₹185.62 |
| Equity | ₹50.52 | ₹82.14 | ₹89.64 | ₹117.62 |
| Total Debt | ₹25.06 | ₹24.14 | ₹78.2 | ₹63.42 |
| Cash | ₹0.05 | ₹1.71 | ₹4.44 | ₹0.51 |
| Net Debt | ₹25.01 | ₹22.43 | ₹73.76 | ₹62.91 |
| Working Capital | ₹41.36 | ₹-51.96 | ₹14.7 | ₹47.91 |
Q1 FY2027
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q1 FY2027 | 73.48% ↑ | 0% | 0% | 26.52% ↓ |
| Q4 FY2026 | 73.29% ↑ | 0% | 0% | 26.71% ↓ |
| Q3 FY2026 | 67.43% | — | — | 32.57% |
| Q2 FY2026 | 67.43% | — | — | 32.57% |
| Q1 FY2026 | 67.43% | — | — | 32.57% |
| Q4 FY2025 | 67.43% | — | — | 32.58% ↑ |
| Q3 FY2025 | 67.43% | — | — | 32.56% |
| Q2 FY2025 | 67.43% | — | — | 32.57% |
No recent corporate actions
Ask: "Is CINEVISTA stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.